Société ORIC Pharmaceuticals, Inc. Börse Stuttgart
Actions
4TZ
US68622P1093
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
7 EUR | -1,41 % | +6,77 % | -12,88 % |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Jacob Chacko
CEO | Chief Executive Officer | 45 | 07/05/18 |
Richard Heyman
FOU | Founder | 66 | 01/01/14 |
Director of Finance/CFO | 50 | 01/09/19 | |
Lori Friedman
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/07/19 |
Edna Maneval
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/03/19 |
Pratik Multani
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/09/18 |
Dan Iazzetti
HRO | Human Resources Officer | - | 01/09/22 |
Matthew Panuwat
PRN | Corporate Officer/Principal | 47 | 01/11/18 |
General Counsel | 51 | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Angie You
BRD | Director/Board Member | 51 | 09/11/21 |
Richard Heyman
FOU | Founder | 66 | 01/01/14 |
Mardi Dier
BRD | Director/Board Member | 60 | 02/03/20 |
Lori Kunkel
BRD | Director/Board Member | 66 | 09/06/20 |
Jacob Chacko
CEO | Chief Executive Officer | 45 | 07/05/18 |
Steven Hoerter
BRD | Director/Board Member | 53 | 13/08/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 67 422 307 | 60 981 029 ( 90,45 %) | 0 | 90,45 % |
Coordonnées société
Oric Pharmaceuticals, Inc.
240 East Grand Avenue 2nd Floor
94080, South San Francisco
+650 388 5600
http://www.oricpharma.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+16,44 % | 122 Md | |
+18,94 % | 114 Md | |
+19,62 % | 25,71 Md | |
-25,37 % | 19,02 Md | |
-20,21 % | 15,83 Md | |
-20,20 % | 15,32 Md | |
-47,37 % | 14,88 Md | |
+59,91 % | 14,82 Md | |
+4,35 % | 14,1 Md |
- Bourse
- Actions
- Action ORIC
- Action 4TZ
- Société ORIC Pharmaceuticals, Inc.